We’re tackling aging,
one of life’s greatest mysteries.

Calico is a research and development company whose mission is to harness advanced technologies to increase our understanding of the biology that controls lifespan. We will use that knowledge to devise interventions that enable people to lead longer and healthier lives. Executing on this mission will require an unprecedented level of interdisciplinary effort and a long-term focus for which funding is already in place.

scroll down

We are scientists from the fields of medicine, drug development, molecular biology, genetics, and computational biology.

Through our research we're aiming to devise interventions that slow aging and counteract age-related diseases.

News C4 Therapeutics and Calico Enter Strategic Partnership to Discover Novel Therapeutics Based on Targeted Protein Degradation March 23, 2017 Daphne Koller Named to FiercePharma’s “Fierce Women in Biopharma 2016” List October 13, 2016 Calico Appoints Daphne Koller as Chief Computing Officer August 17, 2016 The Jackson Laboratory and Calico to Investigate Basic Biology of Aging April 26, 2016 David Botstein receives the Double Helix Medal from Cold Spring Harbor Laboratory November 9, 2015 | Cold Spring Harbor Laboratory AncestryDNA and Calico to Research the Genetics of Human Lifespan July 21, 2015 Cynthia Kenyon named one of the “15 Most Amazing Women in Science Today” July 20, 2015 | Business Insider Calico enters into agreement with the Buck Institute to conduct research into the biology of aging and to identify potential therapeutics for age-related diseases April 28, 2015 Calico licenses technology from acclaimed UCSF laboratory March 31, 2015 Calico and QB3 announce partnership to conduct research into the biology of aging and to identify potential therapeutics for age-related diseases March 24, 2015 Broad Institute and Calico announce an extensive collaboration focused on the biology of aging and therapeutic approaches to diseases of aging March 17, 2015 Art Levinson to receive National Medal of Technology and Innovation October 3, 2014 UT Southwestern researchers discover novel class of NAMPT activators for neurodegenerative disease; Calico enters into exclusive collaboration with 2M to develop UTSW technology September 11, 2014 AbbVie and Calico Announce a Novel Collaboration to Accelerate the Discovery, Development, and Commercialization of New Therapies September 3, 2014 Google announces Calico, a new company focused on health and well-being (Google News) September 18, 2013

As we make early progress on our research and goals, our capacity for handling press inquiries is limited. We’ll do our best to be in touch:


Understanding the fundamental science of aging and finding treatments for the associated and intractable diseases will require multi-disciplinary and highly motivated scientists working in a collaborative environment. Calico is dedicated to providing the environment to support creativity and innovation and to enable our scientists to focus on fundamental biology and improving human health. We are currently seeking exceptional candidates who share our passion. If you are interested in joining Calico, please review our current opportunities.

Calico is proud to be an equal opportunity workplace.